Management of patients with thyroid eye disease

Br J Hosp Med (Lond). 2016 Jan;77(1):C6-9. doi: 10.12968/hmed.2016.77.1.C6.

Authors

Efthimia Karra¹, Ahmed Yousseif², Geoffrey E Rose³, Stephanie E Baldeweg⁴

Affiliations

¹ Consultant in Diabetes and Endocrinology at the Royal Free Hospital NHS Trust, London NW3 2QG.
² Consultant Physician in Diabetes and Endocrinology at Ashford and St Peter's Hospital, Chertsey, Surrey.
³ Consultant Ophthalmologist at Moorfields Eye Hospital, London.
⁴ Consultant Physician in Diabetes and Endocrinology at University College London Hospital, London.

PMID: 26903468
DOI: 10.12968/hmed.2016.77.1.C6

No abstract available

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Catheter Ablation / methods
Graves Ophthalmopathy / therapy*
Hormone Replacement Therapy
Humans
Immunosuppressive Agents / therapeutic use
Rituximab / therapeutic use
Smoking Cessation
Surgery, Plastic / methods
Thyroxine / therapeutic use

Substances

Adrenal Cortex Hormones
Immunosuppressive Agents
Rituximab
Thyroxine